# Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

> **NCT04555044** · PHASE4 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 101 (actual)

## Conditions studied

- Essential Fatty Acid Deficiency (EFAD)

## Interventions

- **DRUG:** Clinolipid
- **DRUG:** Intralipid

## Key facts

- **NCT ID:** NCT04555044
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-22
- **Primary completion:** 2022-10-16
- **Final completion:** 2022-11-16
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04555044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04555044, "Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04555044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*